Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to healthcare and medicines. 
Orion Health has been listed on the latest NHS London Procurement Partnership framework developed to give NHS organisations access to modern digital technology.
The company has been listed on the Clinical Digital Solutions Framework for three solutions critical to the development of integrated care and population health management.
Royal Philips (NYSE: PHG, AEX: PHIA), and Elekta (EKTA-B.ST) signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
The extended collaboration builds on the two companies’ successful cooperation in the fast-emerging field of magnetic resonance (MR)-guided adaptive radiation therapy.
The U.S. Food and Drug Administration authorized marketing of a device to help diagnose autism spectrum disorder (ASD). The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential symptoms of the disorder. 
CompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Viamed, one of Spain's leading private hospital groups, announced that Philips has been selected to install the latest advanced diagnostic imaging solutions in clinical centers throughout Viamed's network, supporting the group's healthcare professionals to further improve patient care.